Agilent Unveils Advanced Therapeutics to Integrate US-Canada CDMO Capabilities
Agilent Advanced Therapeutics offers CDMO services spanning oligonucleotides, microbial fermentation, complex chemistry, bioreagents, highly potent APIs, and cell line development, providing integrated end-to-end support from discovery and process development to clinical and commercial manufacturing.
Cell Line Development | 12/03/2026 | By News Bureau
Aragen Introduces CHOMax for Rapid IND-Enabling Clinical Supply
Aragen has launched CHOMax, a fully integrated and royalty-free platform designed to accelerate the journey from DNA to IND-enabling clinical supply in approximately 10 months, combining cell line development, process and analytical development and GMP manufacturing with demonstrated high-performance outcomes.
Cell Line Development | 13/01/2026 | By News Bureau | 142
KBI Biopharma Signs Manufacturing Contract with Alanis Therapeutics
As part of this collaborative agreement, KBI will oversee cell line development, process optimization, analytical and formulation development, and the manufacturing of Alanis’ pre-clinical antagonistic antibody (mAb).
Cell Line Development | 04/12/2024 | By Aishwarya | 389
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy